PCMC
TAK icon

Paragon Capital Management (Colorado)’s Takeda Pharmaceutical TAK Stock Holding History

Paragon Capital Management (Colorado)’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,640
Closed -$22K – 476
2021
Q4 		$22K Buy
+1,640
New +$23K ﹤0.01% 424

Other funds holding TAK

PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Paragon Capital Management (Colorado)'s TAK Position: Q1 2022 in Review

Paragon Capital Management (Colorado) sold out of Takeda Pharmaceutical (TAK) in Q1 2022, closing a stake of 1,640 shares — an estimated $22K sold.

Paragon Capital Management (Colorado) first reported a position in TAK in Q4 2021 and held it in 1 quarter. The position peaked at $22K in Q4 2021. 287 funds tracked by Wall St. Rank hold TAK as of Q1 2022.

  • Paragon Capital Management (Colorado) reported no remaining Takeda Pharmaceutical position as of Q1 2022 after selling out during the quarter.
  • Paragon Capital Management (Colorado) sold 1,640 Takeda Pharmaceutical shares in Q1 2022, an estimated $22K.
  • Paragon Capital Management (Colorado) first reported a position in Takeda Pharmaceutical in Q4 2021 and held it in 1 quarter.
  • Paragon Capital Management (Colorado)'s Takeda Pharmaceutical position peaked at $22K in Q4 2021.
  • 287 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2022.

Based on Paragon Capital Management (Colorado)'s 13F filing for Q1 2022, filed 19 Apr 2022.